Kinnby B, Matsson L, Lecander I
Department of Periodontology, Lund University, School of Dentistry, Malmö.
Scand J Dent Res. 1994 Dec;102(6):334-41.
High concentrations of tissue plasminogen activator (t-PA) and placental type plasminogen activator inhibitor (PAI-2) have previously been found in gingival crevicular fluid (GCF) of adults and children. In the present study, intra-individual comparisons were made of the concentrations of t-PA, urokinase type plasminogen activator (u-PA), PAI-1, and PAI-2 in GCF from the same sites before and after periodontal treatment in eight healthy male volunteers aged 35-46 yr. The gingival state was assessed by exudate measurement, bleeding on standardized probing, and the gingival index of Löe & Silness 3 days before the start of the trial and on the day after completing a 21-day preventive program consisting of instruction and professional cleaning once a week. Eight sites per subject were selected for enzyme analyses, all showing improvement in gingival state during the period. Sampling of GCF at the start and at the end of the trial was done with small disks of Millipore-filter. t-PA and PAI-2 were analyzed with enzyme-linked immunosorbent assays with low method errors. The mean concentrations of t-PA were 0.73 mg/l before treatment and 0.49 mg/l after treatment. The mean concentrations of u-PA were 84.4 micrograms/l before treatment and 101.6 micrograms/l after treatment. PAI-1 was found in three subjects at the detection level. The mean PAI-2 concentrations were 2.19 mg/l before and 1.13 mg/l after treatment. The mean molar ratio PAs/PAI-2 was 0.47 before and 0.48 after treatment. This insignificant change implies a maintained proteolytic balance and indicates that PAI-2 is an important inhibitor of tissue proteolysis.
先前已在成人和儿童的龈沟液(GCF)中发现高浓度的组织型纤溶酶原激活剂(t-PA)和胎盘型纤溶酶原激活剂抑制剂(PAI-2)。在本研究中,对8名年龄在35 - 46岁的健康男性志愿者在牙周治疗前后,同一部位龈沟液中t-PA、尿激酶型纤溶酶原激活剂(u-PA)、PAI-1和PAI-2的浓度进行了个体内比较。在试验开始前3天以及完成一项为期21天的预防计划(包括指导和每周一次专业清洁)后的第2天,通过渗出液测量、标准探诊出血以及Löe & Silness牙龈指数评估牙龈状态。为酶分析选择每个受试者的8个部位,在此期间所有部位牙龈状态均有改善。在试验开始时和结束时,用密理博滤膜小圆盘采集龈沟液样本。采用酶联免疫吸附测定法分析t-PA和PAI-2,方法误差低。治疗前t-PA的平均浓度为0.73 mg/l,治疗后为0.49 mg/l。治疗前u-PA的平均浓度为84.4微克/升,治疗后为101.6微克/升。在3名受试者中检测到PAI-1处于检测水平。治疗前PAI-2的平均浓度为2.19 mg/l,治疗后为1.13 mg/l。治疗前PA/PAI-2的平均摩尔比为0.47,治疗后为0.48。这种不显著的变化意味着蛋白水解平衡得以维持,并表明PAI-2是组织蛋白水解的重要抑制剂。